Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CTNNB1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CTNNB1 is a gene implicated in neurodegeneration research. Key relationships include: therapeutic target, associated with, activates. Associated with ALS, Aging, Als. Connected to 334 entities in the SciDEX knowledge graph.
| Gene Symbol | CTNNB1 |
| Full Name | Catenin Beta 1 |
| Chromosome | 3p22.1 |
| Primary Expression | Ubiquitous, highest in brain |
| Molecular Weight | 85 kDa |
| Amino Acids | 781 aa |
| Pathways | Wnt signaling, Wnt, Wnt pathway |
| UniProt ID | P35222 |
| NCBI Gene ID | 1499 |
| Ensembl ID | ENSG00000100994 |
| OMIM | 116806 |
| GeneCards | CTNNB1 |
| Human Protein Atlas | CTNNB1 |
| Associated Diseases | Als, Alzheimer, Blood-Brain Barrier Integrity, Breast Cancer, Cancer, Carcinoma |
| Known Drugs/Compounds | rapamycin |
| Interactions | TP53, TERT, PI3K, AKT, ANO1, ATG7 |
| KG Connections | 503 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
CTNNB1_gene["CTNNB1<br/>Gene"]
beta_catenin["beta-Catenin<br/>Protein"]
LRP1["LRP1<br/>Receptor"]
TCF3["TCF3<br/>Transcription Factor"]
AXIN2["AXIN2<br/>Wnt Regulator"]
RRM1["RRM1<br/>DNA Repair"]
SQSTM1["SQSTM1/p62<br/>Autophagy Adapter"]
RAB7A["RAB7A<br/>Vesicle Transport"]
ALS["Amyotrophic Lateral<br/>Sclerosis (ALS)"]
MS["Multiple Sclerosis<br/>(MS)"]
neuroinflammation["Neuroinflammation"]
fibrosis["Tissue Fibrosis"]
cancer["Cancer/Tumors"]
wnt_signaling["Wnt Signaling<br/>Pathway"]
cell_adhesion["Cell Adhesion<br/> and Migration"]
synaptic_function["Synaptic Function<br/> and Plasticity"]
CTNNB1_gene --|"encodes"|--> beta_catenin
LRP1 --|"regulates"|--> beta_catenin
beta_catenin --|"interacts_with"|--> TCF3
beta_catenin --|"activates"|--> wnt_signaling
beta_catenin --|"regulates"|--> cell_adhesion
beta_catenin --|"modulates"|--> synaptic_function
wnt_signaling --|"associated_with"|--> AXIN2
beta_catenin --|"activates"|--> RRM1
CTNNB1_gene --|"associated_with"|--> SQSTM1
CTNNB1_gene --|"associated_with"|--> RAB7A
CTNNB1_gene --|"regulates"|--> ALS
CTNNB1_gene --|"therapeutic_target"|--> MS
CTNNB1_gene --|"therapeutic_target"|--> neuroinflammation
CTNNB1_gene --|"therapeutic_target"|--> fibrosis
CTNNB1_gene --|"regulates"|--> cancer
wnt_signaling --|"dysfunction_leads_to"|--> ALS
cell_adhesion --|"impairment_causes"|--> neuroinflammation
synaptic_function --|"disruption_in"|--> MS
style beta_catenin fill:#006494
style wnt_signaling fill:#1b5e20
style cell_adhesion fill:#1b5e20
style synaptic_function fill:#1b5e20
style TCF3 fill:#4a1a6b
style AXIN2 fill:#4a1a6b
style LRP1 fill:#4a1a6b
style ALS fill:#ef5350
style MS fill:#ef5350
style neuroinflammation fill:#ef5350
style cancer fill:#5d4400
style fibrosis fill:#5d4400| Target | Relation | Type | Str |
|---|---|---|---|
| SLC13A3 | upstream_of | gene | 0.95 |
| WNT | involved_in | pathway | 0.95 |
| liver cancer | risk_factor_for | disease | 0.94 |
| Hippocampal Neurogenesis | involved_in | process | 0.90 |
| Autophagy | interacts_with | process | 0.90 |
| Cancer | associated_with | disease | 0.85 |
| Hepatocellular Carcinoma | biomarker_for | disease | 0.85 |
| cancer | regulates | disease | 0.80 |
| GLUTAMINESYNTHETASE | upregulates | enzyme | 0.80 |
| Blood-Brain Barrier Integrity | associated_with | phenotype | 0.80 |
| Capillary Endothelial Cells | expressed_in | cell_type | 0.80 |
| TSPAN1 | interacts_with | gene | 0.80 |
| Hepatocellular Carcinoma | drives | disease | 0.80 |
| Wnt/TGF-β Proliferation Pathway | involved_in | pathway | 0.75 |
| Cancer | activates | disease | 0.75 |
| Carcinoma | associated_with | disease | 0.75 |
| Carcinoma | activates | disease | 0.75 |
| Carcinoma | therapeutic_target | disease | 0.75 |
| Als | regulates | disease | 0.75 |
| Cancer | regulates | disease | 0.75 |
| Als | associated_with | disease | 0.75 |
| Hepatocellular Carcinoma | therapeutic_target | disease | 0.75 |
| Tumor | associated_with | disease | 0.75 |
| Hepatocellular Carcinoma | activates | disease | 0.75 |
| beta-catenin | encodes | protein | 0.72 |
| RRM1 | activates | gene | 0.72 |
| Wnt | activates | pathway | 0.70 |
| CANCER | expressed_in | gene | 0.70 |
| Hepatocellular Carcinoma | associated_with | disease | 0.70 |
| oxidative stress response | participates_in | pathway | 0.70 |
| Tumor | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Hepatitis | activates | disease | 0.65 |
| Inflammation | activates | disease | 0.65 |
| Fibrosis | therapeutic_target | disease | 0.65 |
| Hepatitis | therapeutic_target | disease | 0.65 |
| Cancer | expressed_in | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Inflammation | therapeutic_target | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Tumor | regulates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Aging | expressed_in | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Dementia | expressed_in | disease | 0.65 |
| Cancer | therapeutic_target | disease | 0.65 |
| Tumor | therapeutic_target | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Cancer | biomarker_for | disease | 0.65 |
| Source | Relation | Type | Str |
|---|---|---|---|
| h-eef1be45 | targets_gene | hypothesis | 0.90 |
| CRTH2 | modulates | receptor | 0.85 |
| CRTH2 | regulates | receptor | 0.85 |
| TDP43 | regulates | protein | 0.85 |
| AXIN1 | interacts_with | gene | 0.85 |
| FZD3 | activates | gene | 0.80 |
| LMP2 | inhibits | protein | 0.80 |
| TP53 | associated_with | gene | 0.70 |
| ARID1A | associated_with | gene | 0.70 |
| AXIN1 | associated_with | gene | 0.70 |
| CANCER | activates | gene | 0.70 |
| KRAS | associated_with | gene | 0.70 |
| CANCER | associated_with | gene | 0.70 |
| GENES | associated_with | gene | 0.70 |
| AUTOPHAGY | regulates | phenotype | 0.65 |
| LRP1 | regulates | protein | 0.64 |
| TCF4 | associated_with | gene | 0.60 |
| MYC | associated_with | gene | 0.60 |
| LC3 | associated_with | gene | 0.60 |
| MTOR | associated_with | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| TP53 | activates | gene | 0.60 |
| TERT | activates | gene | 0.60 |
| ACVR2A | activates | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| AXIN2 | associated_with | gene | 0.60 |
| P62 | activates | gene | 0.60 |
| GAPDH | associated_with | gene | 0.60 |
| GSK3B | associated_with | gene | 0.60 |
| APC | associated_with | gene | 0.60 |
| FGF20 | therapeutic_target | gene | 0.60 |
| BRG1 | regulates | gene | 0.60 |
| NRCAM | therapeutic_target | gene | 0.60 |
| NOTCH2 | therapeutic_target | gene | 0.60 |
| EP300 | regulates | gene | 0.60 |
| UBIQUITIN | inhibits | gene | 0.60 |
| BCL2 | therapeutic_target | gene | 0.60 |
| FOS | therapeutic_target | gene | 0.60 |
| TP53 | therapeutic_target | gene | 0.60 |
| FYN | expressed_in | gene | 0.60 |
| VCP | interacts_with | gene | 0.60 |
| ALDH1A1 | therapeutic_target | gene | 0.60 |
| MITF | therapeutic_target | gene | 0.60 |
| LEF1 | therapeutic_target | gene | 0.60 |
| ABCB1 | therapeutic_target | gene | 0.60 |
| CLDN1 | therapeutic_target | gene | 0.60 |
| JAG1 | therapeutic_target | gene | 0.60 |
| MMP9 | activates | gene | 0.60 |
| CD44 | therapeutic_target | gene | 0.60 |
| NFKB1 | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
neurodegeneration | 2026-04-03 | 7 hypotheses Top: 0.529
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||